NCT06546930Active, not recruiting
Device Use Reimagined Through Education And Mentorship
Optimizing Diabetes Technology Use for Latinx Youth Through DREAM (Device Use Reimagined Through Education And Mentorship) Virtual Peer Groups [Study-wide] - DREAM Intervention
Source: ClinicalTrials.gov · Last updated 1 May 2026
Brief summary (registry, in English)
Diabetes technology, such as insulin pumps and continuous glucose monitoring devices, can help improve glucose control for people with type 1 diabetes (T1D), which keeps them at lower risk for diabetes complications, but many Latinx adolescents, who make up the largest marginalized ethnic group of youth with T1D in California, use these devices less often and have less optimal glucose control compared to White youth. In phase 1 of this project, we worked directly with Latinx youth, their families, and diabetes care team members in California to develop DREAM, Device use Reimagined through Education And Mentorship, a virtual peer group (VPG) intervention that will encourage and support the use of diabetes devices in Latinx adolescents with T1D. The goals for phase 2 (intervention) of this project are to evaluate the feasibility and acceptability of the stakeholder-informed VPG intervention, and evaluate clinical and person-centered outcomes.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 2 Aug 2024
- Start date
- 11 Oct 2024
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- University of California, San Francisco
- Diseases
- Type 1 diabetes
- NCT number
- NCT06546930
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 11 Oct 2024 to the primary completion date, 31 Jul 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants who have a medical, developmental, or psychiatric condition that would make peer group participation difficult
Other
- Adolescents who are planning to transfer care to a different medical center within the next year, which would prevent assessment of longitudinal outcomes
Who the study is looking for
- Adolescents 13-17 years old and their caregivers
- Adolescent must have T1D of any duration, and be receiving diabetes care at UCSF, CHLA or UC Davis
- Self-identify as Latina/o/x or other variations such as Hispanic
- Preferred language of English or Spanish
Age in the registry: 13 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California, Davis Coordinator of this site? Confirm its status | Davis | United States | Unknown status |
| Children's Hospital Los Angeles Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.